Protective effect of Acanthopanax senticosus extract against endotoxic shock in mice

Journal of Ethnopharmacology

Volumn 118, Issue 3, 2008, Pages 495-502

  Lin, Qiu Ye ^a,b   Jin, Li Ji ^a   Cao, Zhen Hui ^b   Li, Hua Qiang ^c   Xu, Yong Ping ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b YUNNAN AGRICULTURAL UNIVERSITY   (China)

^c LIAONING NORMAL UNIVERSITY   (China)

Author keywords

Acanthopanax senticosus; Anti inflammatory effect; Araliaceae; Interleukin 10; Nuclear factor kappa B; Tumor necrosis factor alpha

Indexed keywords

ELEUTHEROCOCCUS SENTICOSUS EXTRACT; GALACTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; ELEUTHEROCOCCUS SENTICOSUS; FEMALE; HEART; HISTOPATHOLOGY; IMMUNOMODULATION; LIVER; LUNG; MOUSE; NONHUMAN; SEPTIC SHOCK;

ACANTHOPANAX; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

ARALIACEAE; ELEUTHEROCOCCUS SENTICOSUS; MUS;

EID: 47749111288     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.05.018     Document Type: Article

References (42)

1. Angus D.C., Linde-Zwirbe W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29 (2001) 1303-1310
2. Baeuerle P.A., and Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursors of the NF-κB transcription factor. Cell 55 (1988) 211-217
3. Bone R.C., Grodzin C.J., and Balk R.A. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 112 (1997) 235-243
4. Brekhman I.I., and Dardymov I.V. New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology 9 (1969) 419-430
5. Davydov M., and Krikorian A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. Journal of Ethnopharmacology 72 (2000) 345-393
6. Enomoto N., Takei Y., Hirose M., Kitamura T., Ikejima K., and Sato N. Protective effect of thalidomide on endotoxin-induced liver injury. Alcoholism, Clinical And Experimental Research 27 (2003) 2S-6S
7. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. Interleukin-10 inhibits cytokine: production by activated macrophages. Journal of Immunology 147 (1991) 3815-3822
8. Frasnsworth N.R., Kinghorn D., Soejarto D.D., and Waller D.P. Siberian ginseng (Eleutherococcus senticosus): current status as an adaptogen. In: Wagner H., Hikino H., and Fransworth N.R. (Eds). Economic and Medicinal Plant Research vol. 1 (1985), Academic Press, London 155-215
9. Friedman G., Silva E., and Vincent J.L. Has the mortality of septic shock changed with time?. Critical Care Medicine 26 (1998) 2078-2086
10. Fujikawa T., Yamaguchi A., Morita I., Takeda H., and Nishibe S. Protective effects of Acanthopanax senticosus Harms from Hokkaido and its components on gastric ulcer in restrained cold water stressed rats. Biological & Pharmaceutical Bulletin 19 (1996) 1227-1230
11. Fujikawa T., Miguchi S., Kanada N., Nakai N., Ogata M., Suzuki I., and Nadashima K. Acanthopanax senticosus Harms as a prophylactic for MPTP-induced Parkinson's disease in rats. Journal of Ethnopharmacology 97 (2005) 375-381
12. Galanos C., Freudenberg M.A., and Reutter W. Galactosamineinduced sensitization to the lethal effects of endotoxin. Proceedings of The National Academy of Sciences of The United States of America 76 (1979) 5939-5943
13. Gutierrez H.H., Pitt B.R., Schwarz M., Watkins S.C., Lowenstein C., Caniggia I., Chumley P., and Freeman B.A. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. American Journal of Physiology-Lung Cellular and Molecular Physiology 268 (1995) L501-L508
14. Haveman J.W., Muller Kobold A.C., Chohen Tervaert J.W., van den Berg A.P., Tulleken J.E., Kallenberg C.G.M., and The T.H. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. The Netherlands Journal of Medicine 55 (1999) 132-141
15. Heinzel F.P., Perko R.M., Ling P., Hakimi J., and Schoenhaut D.S. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of interferon. Infection and Immunity 62 (1994) 4244-4249
16. Howard M., Muchamuel S., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. Journal of Experimental Medicine 177 (1993) 1205-1208
17. Jansen M.J., Hendriks T., Vogels M.T., van der Meer J.W., and Goris R.J. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Critical Care Medicine 24 (1996) 1196-1202
18. Kimura Y., and Sumiyoshi M. Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice. Journal of Ethnopharmacology 95 (2004) 447-453
19. Kopp E.B., and Ghosh S. NF-κB and Rel proteins in innate immunity. Advances in Immunology 58 (1995) 1-27
20. Kumins N.H., Hunt J., Gamelli R.L., and Filkins J.P. Partial hepatectomy reduces the endotoxin-induced peak circulating level of tumor necrosis factor in rats. Shock 5 (1996) 385-388
21. Lin Q.Y., Jin L.J., Cao Z.H., Lu Y.N., Xue H.Y., and Xu Y.P. Acanthopanax senticosus suppresses reactive oxygen species production by mouse peritoneal macrophages in vitro and in vivo. Phytotherapy Research 22 (2007) 740-745
22. Lin Q.Y., Jin L.J., Ma Y.S., Shi M., and Xu Y.P. Acanthopanax senticosus inhibits nitric oxide production in murine macrophages in vitro and in vivo. Phytotherapy Research 21 (2007) 879-883
23. Lin Q.Y., Jin L.J., Cao Z.H., and Xu Y.P. Inhibition of inducible nitric oxide synthase by Acanthopanax senticosus extract in RAW264.7 macrophages. Journal of Ethnopharmacology 118 (2008) 231-236
24. Liu S.F., Ye X., and Malik A.B. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. Journal of Immunology 159 (1997) 3976-3983
25. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43 (1992) 109-142
26. Morikawa A., Kato Y., Sugiyama T., Koide N., Chakravortty D., Yoshida T., and Yokochi T. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in d-galactosamine-sensitized mice as an experimental endotoxic shock model. Infection and Immunity 67 (1999) 1018-1024
27. Nathan C., and Xie Q.W. Nitric oxide synthase: roles, tolls and controls. Cell 78 (1994) 915-918
28. Nishibe S., Kinoshita H., Takeda H., and Okano G. Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chemical & Pharmaceutical Bulletin 38 (1990) 1763-1765
29. Rao K.M. Molecular mechanisms regulating iNOS expression in various cell types. Journal of Toxicology and Environmental Health. Part B: Critical Reviews 3 (2000) 27-58
30. Santucci L., Fiorucci S., Chiorean M., Brunori P.M., Matteo F.M.D., Sidoni A., Miqliorati G., and Morelli A. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 111 (1996) 736-744
31. Stoclet J.C., Muller B., Andriantsitohaina R., and Kleschyov A. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry 63 (1998) 826-832
32. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.W., Nathan C., Gribble G.W., and Sporn M.B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Research 58 (1998) 717-723
33. Suzuki K., Tateda K., Matsumoto T., Gondaira F., Tsujimoto S., and Yamaguchi K. Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice. Journal of Medical Microbiology 49 (2000) 905-910
34. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3 (1995) 2-32
35. Szabo C., Salzman A.L., and Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Letters 363 (1995) 235-238
36. Takemura R., and Werb Z. Secretory products of macrophages and their physiological functions. American Journal of Physiology-Cell Physiology 1246 (1984) C1-C9
37. Wheeler A.P., and Bernard G.R. Treating patients with severe sepsis. New England Journal of Medicine 340 (1999) 207-214
38. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcriptional factor NF-(B/Rel in induction of nitric oxide synthase. Journal of Biological Chemistry 269 (1994) 4705-4708
39. Yang F., Comtois A.S., Fang L., Hartman N.G., and Blaise G. Nitric oxide-derived nitrate anion contributes to endotoxic shock and multiple organ injury/dysfunction. Critical Care Medicine 30 (2002) 650-657
40. Yi J.M., Hong S.H., Kim J.H., Kim H.K., Song H.J., and Kim H.M. Effect of Acanthopanax senticosus stem on mast cell-dependent. Journal of Ethnopharmacology 79 (2002) 347-352
41. Yokozawa T., Rhyu D.Y., and Chen C.P. Protective effects of Acanthopanax Radix extract against endotoxemia induced by lipopolysaccharide. Phytotherapy Research 17 (2003) 353-357
42. Zingarelli B., Sheehan M., and Wong H.R. Nuclear factor-κB as a therapeutic target in critical care medicine. Critical Care Medicine 31 (2003) 105-111